Bilcare Ltd., service provider to the pharmaceutical companies spanning across their value chain from drug discovery to market bags the prestigious 20
Indian deaths from rabies account for nearly 35 percent of such deaths worldwide, according to data available with WHO. Worldwide nearly 55,000 people
- Revenue of 96.44 Cr Highest revenue achieved in a quarter by the company - Net profit of Rs 7.75 Cr - Consolidated turnover at Rs 114.55 Cr
Pharmaceutical and biotechnology major Wockhardt Limited today announced the completion of the divestment of its Animal Health Division to Vétoquinol
Consolidated Sales at Rs. 954 crore Operating Profit (EBIDTA) at Rs. 168 crore Pharmaceutical and biotechnology major Wockhardt Limited today anno
Deal covers India’s leading paediatric and adult nutritional brands Farex and Protinex Pharmaceutical and biotechnology major Wockhardt Limited a
•Records Impressive Performance in Q4 with net sales increase by 33 per cent for the quarter and 41 per cent for the fiscal April 2008- March 09
Q4 Net Income up 16% at Rs.241.72 crore Ankur Drugs and Pharma Ltd., (BSE: 531683), one of the largest contract manufacturers of pharmaceutical for
Pharmaceutical and biotechnology major Wockhardt Limited today announced that the Company and Wockhardt USA LLC, a subsidiary of the Company, have exe
Widens penetration amongst top Pharma companies Cadila Pharmaceuticals, one of India’s most reputed, Research based, Technology intensive pharmac
Cadila Pharmaceuticals, IT & ITES, Logistics, Pharmaceuticals, Products & Services
Revenues for FY2009 up by 14.4% to Rs. 32.8 billion, EBITDA (excluding FOREX impact) for the year was up by 23.7% at Rs. 6.7 billion and Net Profit (e
Financial News, Healthcare, Pharmaceuticals, Piramal Group, Piramal Healthcare Ltd
A New Drug for Breakthrough Cancer Pains Troikaa Pharmaceuticals Ltd has introduced Trofentyl OTFC, lozenge (tablet) for “breakthrough pains” i
Healthcare, Pharmaceuticals, Products & Services, Troikaa Pharmaceuticals
Nektar Therapeutics today announced the appointment of Pushpinder Bindra as Managing Director of Nektar Therapeutics (India) Private Limited, a wholly
Piramal Healthcare Limited (Piramal Healthcare, earlier Nicholas Piramal India Limited) (NSE: PIRHEALTH, BSE: 500302) today reported third quarter (Q3
Financial News, Healthcare, Pharmaceuticals, Piramal Group, Piramal Healthcare Ltd
Piramal Healthcare Limited [NSE: Pirhealth, BSE: 500302], one of India’s largest pharmaceutical and healthcare companies, and Minrad International,
Healthcare, Mergers & Acquistions, Pharmaceuticals, Piramal Group, Piramal Healthcare Ltd
The Board of Directors of Piramal Healthcare Limited (PHL) will meet on Wednesday 22nd October, 2008 to consider the financial results for the quarter
Financial News, Healthcare, Pharmaceuticals, Piramal Healthcare Ltd
Piramal Life Sciences Limited, part of the Piramal Group of companies, has received regulatory approval for the initiation of a phase-I study in India
Healthcare, Pharmaceuticals, Piramal Group, Piramal Healthcare Ltd, Regulations
Piramal Healthcare Limited (PHL, earlier Nicholas Piramal India Limited) (NSE: PIRHEALTH, BSE: 500302) today reported first quarter (Q1) results for F
Financial News, Healthcare, Pharmaceuticals, Piramal Group, Piramal Healthcare Ltd
• Successful execution of Contract Research as per targets set in business plans • Strategically increased market share in all major APIs manufac
Piramal Healthcare Limited [NSE: Pirhealth, BSE: 500302], one of India’s largest pharmaceutical and healthcare companies, and part of the Piramal Gr
Healthcare, Mergers & Acquistions, Nicholas Piramal, Pharmaceuticals, Piramal Group
